Skip to content

Richard Lewis Lipman, M.D.

NPI 1598911133ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· South Miami, FL

Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in South Miami, Florida, licensed in FL, with an NPI issued in August 2008. Part D covered 256 prescriptions written in 2024, 75% of them generic. Lilly USA, LLC reported $39.39 in payments in 2025, mostly food and beverage.

Overview

NPI1598911133
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorYes
NPI issuedAug 14, 2008
Last updated in NPPESMar 7, 2023

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Endocrinology (FL)

Part D prescriptions in 2024

Prescriptions (claims)256 · 494 30-day fills
Patients54
Total drug cost$56,667
Generic share75% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$39.39 · 2 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Lilly USA, LLC$39.392

What the 2025 payments were for

  • Food and Beverage$39.39 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in South Miami

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Florida →